METHOD AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PROSTATIC HYPERPLASIA BASED ON 5ALPHA -REDUCTASE INHIBITOR

摘要

The invention relates to a method and pharmaceuticalcomposition applicable in the treatment of men suffering frombenignant prostatic hyperplasia. By it the patients are appliedwith effective quantity of 5 -reductase inhibitor finasteriderepresenting 17 -(N-tret.-butylcarbamoyl)-4-aza-5-androst-1-en-3-on having the structural formulaor its pharmaceutically acceptable salts in combination withblocker of 1-adrenergetic receptors terazocyn which as1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[tetrahydro-2-furanyl)-carbonyl]piperazine with structural formula3 claims